Dimensional Fund Advisors LP Has $42.01 Million Stock Holdings in Oscar Health, Inc. (NYSE:OSCR)

Dimensional Fund Advisors LP decreased its position in Oscar Health, Inc. (NYSE:OSCR) by 7.3% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 2,653,701 shares of the company’s stock after selling 209,158 shares during the period. Dimensional Fund Advisors LP owned approximately 1.12% of Oscar Health worth $42,011,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Vanguard Group Inc. grew its holdings in shares of Oscar Health by 2.4% in the 1st quarter. Vanguard Group Inc. now owns 14,582,762 shares of the company’s stock valued at $216,846,000 after buying an additional 337,850 shares during the period. Price T Rowe Associates Inc. MD lifted its position in Oscar Health by 153.5% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 3,978,152 shares of the company’s stock worth $59,156,000 after buying an additional 2,409,160 shares in the last quarter. Gilder Gagnon Howe & Co. LLC lifted its position in Oscar Health by 21.0% during the 4th quarter. Gilder Gagnon Howe & Co. LLC now owns 2,830,947 shares of the company’s stock worth $25,903,000 after buying an additional 491,861 shares in the last quarter. First Light Asset Management LLC lifted its position in Oscar Health by 117.3% during the 1st quarter. First Light Asset Management LLC now owns 2,102,554 shares of the company’s stock worth $31,265,000 after buying an additional 1,134,919 shares in the last quarter. Finally, Iron Triangle Partners LP bought a new stake in Oscar Health during the 4th quarter worth about $18,781,000. Institutional investors and hedge funds own 75.70% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have commented on the stock. Wells Fargo & Company boosted their price target on shares of Oscar Health from $24.00 to $27.00 and gave the stock an “overweight” rating in a research report on Wednesday, June 12th. Piper Sandler reaffirmed an “overweight” rating and issued a $28.00 target price on shares of Oscar Health in a report on Tuesday, September 10th. Two analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $24.17.

Insider Activity at Oscar Health

In related news, CAO Victoria Baltrus sold 4,226 shares of the stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total value of $76,025.74. Following the completion of the transaction, the chief accounting officer now owns 140,648 shares of the company’s stock, valued at approximately $2,530,257.52. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. In other news, EVP Alessandrea C. Quane sold 16,793 shares of the firm’s stock in a transaction on Friday, September 6th. The shares were sold at an average price of $17.06, for a total transaction of $286,488.58. Following the completion of the transaction, the executive vice president now owns 392,607 shares of the company’s stock, valued at $6,697,875.42. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CAO Victoria Baltrus sold 4,226 shares of the firm’s stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total transaction of $76,025.74. Following the transaction, the chief accounting officer now directly owns 140,648 shares of the company’s stock, valued at approximately $2,530,257.52. The disclosure for this sale can be found here. Insiders sold a total of 169,569 shares of company stock valued at $3,007,069 in the last quarter. Insiders own 25.11% of the company’s stock.

Oscar Health Stock Performance

NYSE OSCR opened at $21.21 on Tuesday. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.26. The firm has a market capitalization of $5.03 billion, a price-to-earnings ratio of -53.03, a P/E/G ratio of 43.01 and a beta of 1.61. The firm’s 50 day simple moving average is $18.60 and its 200 day simple moving average is $17.89. Oscar Health, Inc. has a 1 year low of $4.72 and a 1 year high of $23.79.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings data on Wednesday, August 7th. The company reported $0.20 EPS for the quarter, beating the consensus estimate of $0.16 by $0.04. The business had revenue of $2.20 billion during the quarter, compared to the consensus estimate of $2.13 billion. Oscar Health had a net margin of 0.25% and a return on equity of 1.86%. The firm’s revenue was up 44.6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned ($0.07) EPS. As a group, research analysts expect that Oscar Health, Inc. will post 0.01 earnings per share for the current fiscal year.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.